Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
October 25, 2025
Approximately 5 minutes
Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices in Japan
Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices in Japan
Overview
This document titled Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices provides detailed guidance about the attached data that must accompany a marketing approval application for reprocessed single-use medical devices (R-SUDs) in Japan. The guidance was issued by the Ministry of Health, Labour and Welfare (MHLW) and applies to R-SUD applications submitted under the Pharmaceuticals and Medical Devices Act (PMD Act). ([turn0search0]; [turn0view0])
The attached data included in an application is critical for proper evaluation of product quality, safety, and equivalence to the original single-use medical device (SUD).
Structure of Attached Data
1. Product Overview
Applicants should provide a clear overview of the R-SUD, including:
- Summary of product characteristics.
- Development history explaining how and why the R-SUD was developed relative to the original SUD.
These should follow formats specified in the Medical Device Attached Data Notification referenced within this guidance. ([turn0view0])
2. Design, Verification and Validation
- Provide comprehensive design details including differences from the original SUD and rationale.
- Include design verification and validation materials (test results, protocols, dates, and outcomes) that support safety and performance.
- Explain any use of OEM devices as test specimens and reasons for alternative selections. ([turn0view0])
3. Comparative Analysis
- Clearly compare the proposed R-SUD to similar devices, including the original SUD, focusing on structure, materials, use, and performance.
- Provide data sources and justification for chosen comparators.
- Include international usage data if the R-SUD or similar products are used outside Japan. ([turn0view0])
4. Conformity with Standards
- Document compliance with Essential Requirements and standards for medical devices.
- Provide checklists and attach test certificates or analysis demonstrating conformity.
- Justify selected specifications where standards do not exist. ([turn0view0])
5. Supplementary Data
- Include any additional supporting data that enhances clarity, such as stability data, safety risk management explanations, or unique distribution details.
- If package inserts are required, provide draft inserts with rationale for warnings, contraindications, and precautions. ([turn0view0])
Q&A
Q: Why is attached data important for R-SUD applications?
A: Attached data provides the PMDA and reviewers with comprehensive proof of design, verification, performance, safety, and comparisons to the original SUD necessary to evaluate the application thoroughly. ([turn0search0]; [turn0view0])
Q: Must attached data include design validation results?
A: Yes. Verification and validation test records must be summarized and attached to support the product’s quality and safety claims. ([turn0view0])
Q: Can international use information be included?
A: Yes. Information about R-SUD use and approval in foreign regions helps contextualize global experience and demonstrate performance consistency. ([turn0view0])
Conclusion
Preparing attached data for an R-SUD marketing approval application requires clear product descriptions, detailed technical data, comparative analyses, conformity documentation, and supplementary evidence where necessary. Proper documentation helps ensure the PMDA can evaluate safety, efficacy, and equivalence effectively. ([turn0search0]; [turn0view0])
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Japan Medical Device Registration: Pathways and Requirements
The medical device registration process in Japan is overseen by the PMDA and varies significantly based on device classification (Class I to IV). Key pathways include Pre-Market Submission (PMS), Pre-Market Certification (PMC), and Pre-Market Approval (PMA).
Approximately 5 minutes
Japan Medical Device Local Labeling Requirements: Tempu Bunsho
Medical device labeling in Japan, specified by PMDA's Article 52, mandates the use of Japanese 'tempu bunsho' (package inserts/IFUs). This process involves rigorous content requirements, notification upon revision, and MAH/DMAH oversight for affixation.
Approximately 5 minutes
Japan Medical Device Post-Market Surveillance (PMS): GVP and Adverse Event Reporting
An overview of Japan's PMS requirements under the PMD Act, focusing on the MAH's GVP compliance, the mandatory reporting of adverse events (Fuguai), and the strict reporting timelines (e.g., 15 days for death or serious, unanticipated events).
Approximately 5 minutes
Japan Specialty Fulfillment for Medical Devices: Low Volume, High Value Sales
Specialty Fulfillment is a crucial service for foreign medical device manufacturers targeting low-volume, high-value sales in Japan, often utilizing an Independent License Holder to manage customs, storage, and distribution to maintain high profit margins.
Approximately 5 minutes
Regulatory Science in Japan: PMDA’s Evidence-Based Approach to Innovation and Public Health
This article explains what “regulatory science” means in Japan and how the PMDA advances it through organizational structures, expert deliberation, collaborations, and research dissemination. A practical Q&A is included for industry and academia.